Bringing clinically-validated AI to outpatients
At AlgoDx, we stand behind the hypothesis that data and AI based predictions can be used to dramatically improve outpatient care in specific diagnoses. This is why we partner up with relevant stakeholders in scientific consortia looking to improve the outpatient experience. In this context, AlgoDx brings AI and regulatory expertise, with the goal to develop medical software that improves patient outcomes.
AlgoDx outpatient clinical pipeline as of May 2022
Pre-Clinical R&D |
Regulatory Clearance EU & US |
Clinical validation in outpatients |
Post-marketing clinical follow-up |
|
---|---|---|---|---|
Ulcerative Colitis | ||||
Crohn's disease | ||||
Undisclosed Therapeutic Indication | ||||
Ongoing
Complete |
Clinical trials – AlgoDx sponsored clinical research
For more information on our ongoing clinical projects, visit clinicaltrials.gov